NRX Pharmaceuticals (NRXP) vs Organigram Global (OGI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
NRX Pharmaceuticals (NRXP) has outperformed Organigram Global (OGI) over the past year, losing 19.3% versus a loss of 51.0%. Over five years, OGI leads with a -89.4% price change compared with -97.2% for NRXP. Organigram Global is the larger company by market cap ($136.8 million vs $123.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NRXP | OGI |
|---|---|---|
| Share price | $2.85 | $0.9487 |
| Market cap | $123.49M | $136.76M |
| 1-day change | -1.30% | -0.25% |
| YTD return | +6.64% | -43.39% |
| 1-year return | -19.27% | -50.97% |
| 5-year return | -97.18% | -89.39% |
| P/E ratio (TTM) | — | 2.21 |
| Forward P/E | — | 39.53 |
| EPS (TTM) | $-0.58 | $0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.06 | $2.24 |
| 52-week low | $1.62 | $0.853 |
| Distance from 52-week high | -43.57% | -57.65% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +1249.79% | — |
| Average volume | 865.49K | 884.72K |
| Shares outstanding | 43.30M | 144.15M |
| Employees | 29 | 1,139 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NRXP has outperformed OGI by 31.7 percentage points over the past year.
About NRX Pharmaceuticals
NRXP stock →NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments.
Health Care · Biotechnology: Pharmaceutical Preparations · 29 employees
About Organigram Global
OGI stock →Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada.
Health Care · Biotechnology: Pharmaceutical Preparations · 1,139 employees
NRXP vs OGI FAQ
Which is bigger, NRX Pharmaceuticals or Organigram Global?
Organigram Global (OGI) is larger, with a market capitalization of $136.76M compared with $123.49M for NRX Pharmaceuticals (NRXP).
Which stock has performed better over the past year, NRXP or OGI?
NRXP returned -19.27% over the past 12 months, compared with -50.97% for OGI (price return, excluding dividends). Past performance does not predict future results.
Are NRX Pharmaceuticals and Organigram Global in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.